Molecular Pathogenesis & Recent Novel Treatment Strategies of Myelodysplastic Syndromes (MDS)
Mahmoud Abdel-Maged Mahmoud;
Abstract
Myelodysplastic syndromes (MDS) are a group of conditions caused by abnormal blood-forming cells of the bone marrow. In myelodysplastic syndromes (MDS), the bone marrow cannot produce blood cells effectively.
These abnormal blood cells are usually destroy
These abnormal blood cells are usually destroy
Other data
| Title | Molecular Pathogenesis & Recent Novel Treatment Strategies of Myelodysplastic Syndromes (MDS) | Authors | Mahmoud Abdel-Maged Mahmoud | Keywords | Molecular Pathogenesis & Recent Novel Treatment Strategies of Myelodysplastic Syndromes (MDS) | Issue Date | 2008 | Description | Myelodysplastic syndromes (MDS) are a group of conditions caused by abnormal blood-forming cells of the bone marrow. In myelodysplastic syndromes (MDS), the bone marrow cannot produce blood cells effectively. These abnormal blood cells are usually destroy |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.